Subcutaneous Administration of Otelixizumab to T1DM Patients

Clinical trial NCT00946257 · COMPLETED

Trial details

NCT number: NCT00946257
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2009-07-08
Primary completion: 2011-08-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.